Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Equity (2017 - 2021)

Historic Return on Equity for ENDRA Life Sciences (NDRA) over the last 5 years, with Q3 2021 value amounting to 0.74%.

  • ENDRA Life Sciences' Return on Equity rose 58900.0% to 0.74% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.74%, marking a year-over-year increase of 58900.0%. This contributed to the annual value of 1.97% for FY2020, which is 4500.0% up from last year.
  • Per ENDRA Life Sciences' latest filing, its Return on Equity stood at 0.74% for Q3 2021, which was up 58900.0% from 0.67% recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Return on Equity registered a high of 2.76% during Q1 2017, and its lowest value of 13.11% during Q3 2018.
  • Over the past 5 years, ENDRA Life Sciences' median Return on Equity value was 2.23% (recorded in 2020), while the average stood at 3.22%.
  • As far as peak fluctuations go, ENDRA Life Sciences' Return on Equity tumbled by -126100bps in 2018, and later surged by 75900bps in 2021.
  • ENDRA Life Sciences' Return on Equity (Quarter) stood at 0.86% in 2017, then tumbled by -291bps to 3.38% in 2018, then decreased by -28bps to 4.32% in 2019, then skyrocketed by 48bps to 2.23% in 2020, then skyrocketed by 67bps to 0.74% in 2021.
  • Its Return on Equity was 0.74% in Q3 2021, compared to 0.67% in Q2 2021 and 0.85% in Q1 2021.